LBL.V -- Stem cell based CoronaVirus treatment; VOLUME!
LBL.V is hitting highest volume on TSX-V today. Very similar setup to VXL.V from last week, just before it made the big move from .14 to .325 but cheaper and much better financials. Cash flow positive. $8.4M market cap. 93M shares out.
See the most recent news release with regards to positive outcomes in applying their technology to treat the Coronavirus patients in China:
"Recently published results from an investigator-initiated clinical study conducted in China which reported that allogeneic mesenchymal stem cells (MSCs) cured or significantly improved functional outcomes in all seven treated patients with severe COVID-19 pneumonia."
Google "Lattice Biologics to Evaluate Anti-Inflammatory Stem Cell Therapy Treatment of COVID-19 Lung Disease"
See the most recent news release with regards to positive outcomes in applying their technology to treat the Coronavirus patients in China:
"Recently published results from an investigator-initiated clinical study conducted in China which reported that allogeneic mesenchymal stem cells (MSCs) cured or significantly improved functional outcomes in all seven treated patients with severe COVID-19 pneumonia."
Google "Lattice Biologics to Evaluate Anti-Inflammatory Stem Cell Therapy Treatment of COVID-19 Lung Disease"
Komen:
Well, that worked out ok :)
Dagangan ditutup: sasaran tercapai
